You are here: Home » News-CM » Companies » News
Business Standard

Unichem Laboratories receives approval from USFDA for hydrocloride tablets

Capital Market 

On 07 May 2019

Limited announced that it received tentative ANDA approval from USFDA for Unichem's Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets USP, 5 mg/120 mg (OTC) to market a generic version of Inc's Zyrtec-D 12 Hour (Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride, 5mg/120 mg) Extended Tablets. These are indicated for antihistamine and nasal decongestant. The Product will be commercialized from on receipt of final approval.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, May 07 2019. 12:21 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU